[
  {
    "ts": null,
    "headline": "Nasdaq Halts Charming Medical Limited",
    "summary": "NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading is halted in Charming Medical Limited (Nasdaq: MCTA) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in MCTA from 04:00:00 on November 12, 2025 to 23:59:00 on November 25, 2025. The last sale price of the company’s ordinary shares was $29.355. More information about the SEC’s order can be found at https:",
    "url": "https://finnhub.io/api/news?id=834058fc5a285138f9c2eb533656cf688c9bc25067a3a70ef8564a386e20a375",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764158400,
      "headline": "Nasdaq Halts Charming Medical Limited",
      "id": 137611734,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "NDAQ",
      "source": "Yahoo",
      "summary": "NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading is halted in Charming Medical Limited (Nasdaq: MCTA) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in MCTA from 04:00:00 on November 12, 2025 to 23:59:00 on November 25, 2025. The last sale price of the company’s ordinary shares was $29.355. More information about the SEC’s order can be found at https:",
      "url": "https://finnhub.io/api/news?id=834058fc5a285138f9c2eb533656cf688c9bc25067a3a70ef8564a386e20a375"
    }
  },
  {
    "ts": null,
    "headline": "Nasdaq AxiomSL Expands RegTech Deployment with Revolut, Accelerating Global Growth",
    "summary": "Integrated regulatory reporting and risk platform to support Revolut’s expanding global footprintLONDON and NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Nasdaq today announced a significant expansion of its strategic regulatory technology partnership with global fintech Revolut. The partnership centers on the deployment of Nasdaq AxiomSL, a regulatory reporting and risk platform used by 90% of global systemically important banks (G-SIBs) to comply with domestic and international regulatory obliga",
    "url": "https://finnhub.io/api/news?id=3e8c67cc58512cfcd70580080a29445e10d56b1d6d7ff9325fc9cf2e3712b1fd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764144000,
      "headline": "Nasdaq AxiomSL Expands RegTech Deployment with Revolut, Accelerating Global Growth",
      "id": 137611735,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "NDAQ",
      "source": "Yahoo",
      "summary": "Integrated regulatory reporting and risk platform to support Revolut’s expanding global footprintLONDON and NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Nasdaq today announced a significant expansion of its strategic regulatory technology partnership with global fintech Revolut. The partnership centers on the deployment of Nasdaq AxiomSL, a regulatory reporting and risk platform used by 90% of global systemically important banks (G-SIBs) to comply with domestic and international regulatory obliga",
      "url": "https://finnhub.io/api/news?id=3e8c67cc58512cfcd70580080a29445e10d56b1d6d7ff9325fc9cf2e3712b1fd"
    }
  }
]